FOR HEALTHCARE PROFESSIONALS ONLY
Home
Articles
Sanofi branded clouded background image

Latest Articles

A checklist of pathology where CBC is checked

ArticleJul 8, 2025

Blood Eosinophils as a Biomarker in Patients with COPD

This article discusses the role of blood eosinophils as a biomarker in patients with Chronic Obstructive Pulmonary Disease (COPD). It highlights that measuring blood eosinophil levels can help predict exacerbations, guide corticosteroid therapy, and tailor treatment strategies for COPD patients. The article emphasizes the importance of personalized treatment approaches based on eosinophil counts to improve patient outcomes and manage COPD more effectively.

Learn more
a man breathing in a machine

ArticleJul 3, 2025

What tests can help diagnose and monitor your patients with COPD?

Chronic Obstructive Pulmonary Disease (COPD) is typically suspected in patients with symptoms like dyspnea, chronic cough, or sputum production. Accurate diagnosis is crucial for effective management, with spirometry being essential for confirmation. Distinguishing COPD from similar conditions, such as asthma, is challenging yet vital. This article provides clear guidance on differentiating COPD from asthma and highlights key tools like spirometry and validated questionnaires for monitoring disease progression and guiding treatment. Understanding and applying these tools can significantly enhance patient outcomes in COPD management.

Learn more
A nurse helping an elderly person down the stairs.

ArticleJul 3, 2025

Key tools to measure the success of COPD management

This article provides pulmonologists with essential insights into evaluating COPD management. It delves into the multifaceted approach required to measure success, including reducing symptom severity, preventing exacerbations, improving lung function, enhancing exercise tolerance, and boosting the quality of life. By employing standardized assessment tools such as the COPD Assessment Test (CAT), modified Medical Research Council (mMRC) dyspnea scale, and St. George’s Respiratory Questionnaire (SGRQ), clinicians can accurately gauge treatment effectiveness. Additionally, the article highlights the importance of continuous assessment and adjustment in managing COPD, ensuring better patient outcomes.

Learn more

ArticleMay 23, 2025

A video series on round table discussions featuring experts: Different inflammatory pathways in COPD impacting disease pathobiology and progression

The article "How do different inflammatory pathways in COPD impact disease pathobiology and progression?" features insights from a round table discussion involving leading respiratory experts. It focuses on chronic obstructive pulmonary disease (COPD), a heterogeneous and progressive condition. The experts delved into the inflammatory processes in COPD, particularly type 2 pathway and its associated endotype, emphasizing the importance of identifying patients by endotypes.

Learn more
Nurse placing a respiratory mask on a patient

ArticleMay 23, 2025

Navigating the Hidden Burden: The Critical Role of Moderate Exacerbations in COPD

Exacerbations are key events in COPD1 that play a crucial role in disease progression. Although often managed in outpatient settings, exacerbations contribute significantly to the overall burden of COPD.2 These events are characterized by an acute worsening of respiratory symptoms, including increased dyspnea associated with cough and production of purulent sputum, increased wheezing and chest discomfort.1,3 These characteristics reflect an underlying inflammatory response2 that exacerbates the disease process.

Learn more
123